Cochleovestibular Screening in Neurosarcoidosis

Hearing loss, tinnitus, and vertigo are common symptoms with a long list of possible causes. Sometimes, the root lies not in the ear itself, but in the nervous system. A study led by Achraf Hafdi and colleagues at the University Hospital of Marrakech highlights one such rare culprit: neurosarcoidosis. Their research shows that this condition can directly disrupt the auditory and balance systems, but also that treatment can often bring significant relief.

How Neurosarcoidosis Affects Hearing and Balance

Sarcoidosis is an inflammatory disease where tiny clusters of cells called granulomas form in various organs, most often the lungs and lymph nodes. In about 5-15% of cases, it affects the nervous system, becoming neurosarcoidosis. These granulomas can develop on or around cranial nerves, including the vestibulocochlear nerve responsible for hearing and balance.

When this nerve or its surrounding structures are involved, the result can be sensorineural hearing loss, persistent tinnitus, and episodes of vertigo. The inflammation essentially disrupts the signal pathway between the inner ear and the brain. Hafdi’s team set out to document how often and in what ways these cochleovestibular symptoms appear in patients with neurosarcoidosis.

Study Design and Diagnostic Approach

The researchers conducted a retrospective analysis of 21 patients diagnosed with neurosarcoidosis over a three-year period. All patients underwent a thorough screening in the otolaryngology department. The diagnostic process was comprehensive, reflecting the challenge of pinpointing neurosarcoidosis.

Each patient had a full neurological examination and imaging studies, typically MRI, to identify granulomas affecting cranial nerves. For hearing and balance function, they received pure tone audiometry (PTA) to measure hearing loss and video nystagmography (VNG) to assess vestibular (balance) system function. This combination of clinical, radiological, and functional testing is essential, as symptoms alone can resemble more common conditions like sudden sensorineural hearing loss or Meniere’s disease.

Findings: A Range of Symptoms With a Promising Response to Treatment

The 21 patients presented with diverse neurological issues, but cochleovestibular symptoms were a major feature. Audiometric tests confirmed varying degrees of hearing loss. Tinnitus and vertigo were prominent and distressing complaints for many.

Critically, imaging studies provided the link, revealing sarcoid granulomas affecting multiple cranial nerves, with clear involvement of the vestibulocochlear nerve and adjacent areas in many cases. This provided a clear anatomical explanation for the patients’ symptoms.

The most encouraging data came from treatment outcomes. Patients were treated with standard therapies for neurosarcoidosis, primarily corticosteroids and other immunosuppressive agents. At their last follow-up, 57% reported noticeable improvement in their hearing loss, tinnitus, and vertigo. This suggests that suppressing the underlying inflammation can help restore function, highlighting the importance of correct diagnosis.

Why This Matters for Patients and Clinicians

This study has direct practical implications. For individuals experiencing unexplained hearing loss, tinnitus, or vertigo—especially if accompanied by other neurological signs like facial weakness or headaches—neurosarcoidosis should be part of the differential diagnosis. It is rare, but missing it can delay appropriate treatment.

For doctors, the research reinforces the need for a multidisciplinary approach. Otolaryngologists and neurologists must collaborate when a patient presents with isolated audiovestibular symptoms that don’t fit a typical pattern. A detailed MRI scan can be decisive. The improvement seen with anti-inflammatory treatment also underscores that these symptoms are not always permanent; targeted intervention can help. This principle of addressing the root inflammatory cause is also explored in research on other conditions, such as autoimmune encephalitis.

Connecting to Broader Hearing Health

The findings from Morocco align with a broader understanding in hearing health: problems perceived in the ear often have origins in the central nervous system. The success of immunosuppressive treatment for neurosarcoidosis-related symptoms adds to the evidence that neuroinflammation is a viable target for certain types of hearing and balance disorders. This concept is driving investigation into other treatments, including neuromodulation techniques that aim to calm overactive neural circuits involved in conditions like tinnitus.

Hafdi, Chehbouni, and Oulghoul conclude that early detection of neurosarcoidosis through comprehensive evaluation is key to managing its hearing and balance consequences. Their work serves as a reminder that effective treatment begins with an accurate diagnosis, even for the rarest of causes.

Source: Hafdi A, Chehbouni M, Oulghoul O. Evaluation of the cochleovestibular manifestations in neurosarcoidosis. International Journal of Science and Research Archive. 2026;19(2):01-06. DOI: 10.30574/ijsra.2026.19.2.1195.